Evercore ISI Group Initiates Coverage On Mineralys Therapeutics with Outperform Rating
Evercore ISI Group analyst Umer Raffat initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Outperform rating.
Credit Suisse Initiates Coverage On Mineralys Therapeutics with Outperform Rating, Announces Price Target of $40
Credit Suisse analyst Richard Law initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Outperform rating and announces Price Target of $40.
Guggenheim Initiates Coverage On Mineralys Therapeutics with Buy Rating, Announces Price Target of $32
Guggenheim analyst Seamus Fernandez initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Buy rating and announces Price Target of $32.
B of A Securities Initiates Coverage On Mineralys Therapeutics with Buy Rating, Announces Price Target of $39
B of A Securities analyst Greg Harrison initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Buy rating and announces Price Target of $39.
Roth MKM Initiates Coverage On Tenax Therapeutics with Buy Rating, Announces Price Target of $6
Roth MKM analyst Jonathan Aschoff initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Buy rating and announces Price Target of $6.
Goldman Sachs Initiates Coverage On Arista Networks with Buy Rating
Goldman Sachs analyst Michael Ng initiates coverage on Arista Networks (NYSE:ANET) with a Buy rating.
Goldman Sachs Initiates Coverage On Cisco Systems with Neutral Rating
Goldman Sachs analyst Michael Ng initiates coverage on Cisco Systems (NASDAQ:CSCO) with a Neutral rating.
Stifel Initiates Coverage On Mineralys Therapeutics with Buy Rating, Announces Price Target of $45
Stifel analyst Annabel Samimy initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Buy rating and announces Price Target of $45.
Roth MKM Reinstates Buy on aTyr Pharma, Announces $9 Price Target
Roth MKM analyst Kumaraguru Raja reinstates aTyr Pharma (NASDAQ:LIFE) with a Buy and announces $9 price target.
JP Morgan Assumes General Electric at Neutral, Announces Price Target of $88
JP Morgan analyst Seth Seifman assumes General Electric (NYSE:GE) with a Neutral rating and announces Price Target of $88.